INCYTE CORPORATION Available-for-sale Securities, Amortized Cost Basis
INCYTE CORPORATION (INCY) had Available-for-sale Securities, Amortized Cost Basis of $185.84 million as of 2015-06-30, per its 10-Q filed 2015-08-04.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2016-02-12
- 2015-06-30: Available-for-sale Securities, Amortized Cost Basis $185.84M.
- 2015-03-31: Available-for-sale Securities, Amortized Cost Basis $161.34M.
- 2014-12-31: Available-for-sale Securities, Amortized Cost Basis $146.15M.
- 2014-09-30: Available-for-sale Securities, Amortized Cost Basis $148.44M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2015-06-30 | $185.84M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $161.34M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $146.15M 10-K · filed 2016-02-12 |
| 2014-09-30 | $148.44M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $100.41M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $80.61M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $35.58M 10-K · filed 2015-02-17 |
| 2013-09-30 | $17.04M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $17.26M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $2.37M 10-Q · filed 2013-05-02 |
| 2012-12-31 | $2.48M 10-K · filed 2014-02-21 |
| 2012-09-30 | $2.70M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $2.85M 10-Q · filed 2012-08-03 |
| 2012-03-31 | $3.18M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $3.34M 10-K · filed 2013-02-21 |
| 2011-09-30 | $3.50M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $3.74M 10-Q · filed 2011-07-28 |
| 2010-12-31 | $4.90M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |